AstraZeneca PLC (NASDAQ:AZN)
| 57.86 BATS BZX Real-Time Price As of 1:39pm ET |  -0.465 / -0.80%Today’s Change | 46.48 Today|||52-Week Range 64.94 | +15.74% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 58.33 |
| Today’s open | 58.19 |
| Day’s range | 57.83 - 58.32 |
| Volume | 284,767 |
| Average volume (3 months) | 9,236,002 |
| Market cap | $153.3B |
Data as of 1:39pm ET, 06/22/2021
Growth & Valuation
| Earnings growth (last year) | +138.26% |
| Earnings growth (this year) | +34.03% |
| Earnings growth (next 5 years) | +19.50% |
| Revenue growth (last year) | +13.57% |
| P/E ratio | 38.2 |
| Price/Sales | 4.72 |
| Price/Book | 9.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | -1.02 | -1.53% |
| NVONovo Nordisk | -0.53 | -0.64% |
| SNYSanofi | -0.44 | -0.84% |
| LLYEli Lilly and Co | -1.24 | -0.56% |
Data as of 1:39pm ET, 06/22/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.49 |
| Annual revenue (last year) | $27.8B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
